BioCardia
BCDA
22 hedge funds and large institutions have $791K invested in BioCardia in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.13% less ownership
Funds ownership: 0.63% → 0.5% (-0.13%)
8% less funds holding
Funds holding: 24 → 22 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
42% less capital invested
Capital invested by funds: $1.37M → $791K (-$574K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$53.1K |
| 2 |
OWA
Octavia Wealth Advisors
Cincinnati,
Ohio
|
+$6.8K |
| 3 |
PP
Pingora Partners
Wilson,
Wyoming
|
+$3.91K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$3.44K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$1.91K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$59K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$43.5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$16.1K |
| 4 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
-$14.9K |
| 5 |
VF
Virtu Financial
New York
|
-$13K |
BCDA Hedge Fund Activity: Q1 2024 in Review
22 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q1 2024, worth a combined $791K — down 42% from $1.37M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of BCDA and 3 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 4 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $53.1K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $59K sold.
- 22 institutional investors held BioCardia (BCDA) as of Q1 2024, down from 24 in Q4 2023.
- Funds reported $791K of BioCardia stock for Q1 2024, down 42% quarter-over-quarter.
- 3 funds opened new BioCardia positions in Q1 2024 and 5 closed out, a net change of -2 holders.
- The largest BioCardia buyer in Q1 2024 was Two Sigma Securities, an estimated $53.1K added.
- The largest BioCardia seller in Q1 2024 was Renaissance Technologies, an estimated $59K sold.
Based on aggregated 13F filings for Q1 2024.